Literature DB >> 15297963

Current challenges and opportunities for research on borderline ovarian tumors.

Mark E Sherman1, Jules Berman, Michael J Birrer, Kathleen R Cho, Lora Hedrick Ellenson, Fred Gorstein, Jeffrey D Seidman.   

Abstract

This article summarizes key issues for future research on borderline ovarian tumors that emerged at a National Cancer Institute-sponsored Borderline Ovarian Tumor Workshop held in August 2003 in Bethesda, MD. Limitations in existing research and opportunities for future advances have been highlighted. The application of new molecular techniques in combination with improved study designs holds promise for elucidating the pathogenesis of these tumors and revealing the source of the extra-ovarian lesions ("implants") with which they are frequently associated. Clarification of the etiology of borderline tumors and the pathogenesis of their associated implants is critical for improving pathological diagnosis, revising the classification system of ovarian neoplasms, and developing optimal, evidence-based clinical management algorithms.

Entities:  

Mesh:

Year:  2004        PMID: 15297963     DOI: 10.1016/j.humpath.2004.03.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Management of Borderline Ovarian Tumors-Still a Gray Zone.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2017-08-25

Review 2.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

3.  Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.

Authors:  Russell Vang; Charlotte G Hannibal; Jette Junge; Kirsten Frederiksen; Susanne K Kjaer; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

4.  Borderline ovarian tumor in pregnancy: can surgery wait? A case series.

Authors:  Ailyn M Vidal Urbinati; Anna D Iacobone; Raffaela C Di Pace; Ida Pino; Maria R Pittelli; Maria E Guerrieri; Eleonora P Preti; Dorella Franchi
Journal:  Arch Gynecol Obstet       Date:  2021-05-05       Impact factor: 2.344

5.  Fertility-Preserving Surgery of Borderline Serous Ovarian Tumors: A Case Report.

Authors:  Ipsita Mohapatra; Subha R Samantaray; Nikku Harshini
Journal:  Cureus       Date:  2022-04-13

6.  Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

Authors:  Michael S Anglesio; Jeremy M Arnold; Joshy George; Anna V Tinker; Richard Tothill; Nic Waddell; Lisa Simms; Bianca Locandro; Sian Fereday; Nadia Traficante; Peter Russell; Raghwa Sharma; Michael J Birrer; Anna deFazio; Georgia Chenevix-Trench; David D L Bowtell
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

7.  Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.

Authors:  Katherine Stemke-Hale; Kristy Shipman; Isidora Kitsou-Mylona; David G de Castro; Vicky Hird; Robert Brown; James Flanagan; Hani Gabra; Gordon B Mills; Roshan Agarwal; Mona El-Bahrawy
Journal:  Mod Pathol       Date:  2012-11-23       Impact factor: 7.842

8.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.

Authors:  F E van Leeuwen; H Klip; T M Mooij; A M G van de Swaluw; C B Lambalk; M Kortman; J S E Laven; C A M Jansen; F M Helmerhorst; B J Cohlen; W N P Willemsen; J M J Smeenk; A H M Simons; F van der Veen; J L H Evers; P A van Dop; N S Macklon; C W Burger
Journal:  Hum Reprod       Date:  2011-10-26       Impact factor: 6.918

9.  Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany.

Authors:  A Coumbos; J Sehouli; R Chekerov; D Schaedel; G Oskay-Oezcelik; W Lichtenegger; W Kuehn
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

Review 10.  Controversies in borderline ovarian tumors.

Authors:  Seok Ju Seong; Da Hee Kim; Mi Kyoung Kim; Taejong Song
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.